Chapter 1. Consumer Healthcare Market– Scope & Methodology
   1.1. Market Segmentation
   1.2. Scope, Assumptions & Limitations
   1.3. Research Methodology
   1.4. Primary Sources
   1.5. Secondary Sources
 
Chapter 2. Consumer Healthcare Market– Executive Summary
   2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
   2.2. Key Trends & Insights
           2.2.1. Demand Side
           2.2.2. Supply Side
   2.4. Attractive Investment Propositions
   2.5. COVID-19 Impact Analysis
 
 
Chapter 3. Consumer Healthcare Market– Competition Scenario
   3.1. Market Share Analysis & Company Benchmarking
   3.2. Competitive Strategy & Development Scenario
   3.3. Competitive Pricing Analysis
   3.4. Supplier-Distributor Analysis
 
 
Chapter 4. Consumer Healthcare Market- Entry Scenario
    4.1. Regulatory Scenario
    4.2. Case Studies – Key Start-ups
    4.3. Customer Analysis
    4.5. PESTLE Analysis
    4.4. Porters Five Force Model
               4.4.1. Bargaining Power of Suppliers
               4.4.2. Bargaining Powers of Customers
               4.4.3. Threat of New Entrants
               4.4.4. Rivalry among Existing Players
                4.4.5. Threat of Substitutes
 
 
Chapter 5. Consumer Healthcare Market- Landscape
   5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
   5.2. Market Drivers
   5.3. Market Restraints/Challenges
   5.4. Market Opportunities
 
 Chapter 6. Consumer Healthcare Market– By Application
  6.1.  Introduction/Key Findings   
6.2    Retail
6.3    Online
6.4     Hospitals
6.5    Y-O-Y Growth trend Analysis By Application 
6.6    Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 7. Consumer Healthcare Market - By Type
 7.1.  Introduction/Key Findings   
7.2     OTC Pharmaceuticals
7.3    Dietary Supplements
7.4    Y-O-Y Growth trend Analysis By Type
7.5    Absolute $ Opportunity Analysis By Type, 2023-2030
Chapter 8. Consumer Healthcare Market, By Geography – Market Size, Forecast, Trends & Insights
   8.1. North America
                                8.1.1. By Country
                                           8.1.1.1. U.S.A.
                                                8.1.1.2. Canada
                                                8.1.1.3. Mexico

                                    8.1.3 By Application 
8.1.4. By Type

8.1.5. Countries & Segments - Market Attractiveness Analysis
   8.2. Europe
                               8.2.1. By Country
                                                8.2.1. U.K.                         
                                                8.2.2. Germany
                                                8.2.3. France
                                                8.2.4. Italy
                                                8.2.5. Spain
                                                8.2.6. Rest of Europe

                           8.2.2 By Application
8.2.3. By Type

8.2.4. Countries & Segments - Market Attractiveness Analysis
8.3. Asia Pacific
                                8.3.1. By Country
                                                8.3.1. China
                                                8.3.2. Japan
                                                8.3.3. South Korea
                                                8.3.4. India      
                                               8.3.5. Australia & New Zealand
                                                8.3.6. Rest of Asia-Pacific
8.3.2. By Application 
8.3.3. By Type

8.3.4. Countries & Segments - Market Attractiveness Analysis
8.3.5. South America
                                8.4.1. By Country
                                                8.4.1. Brazil
                                                8.4.2. Argentina
                                                8.4.3. Colombia
                                               8.4.4. Chile
                                                8.4.5. Rest of South America                         
                                 8.4.2. By Application
8.4.3. By Type

8.4.4. Countries & Segments - Market Attractiveness Analysis
 8.4.5. Middle East & Africa
                                8.5.1. By Country
                                                8.5.1. United Arab Emirates (UAE)
                                               8.5.2. Saudi Arabia
                                                8.5.3. Qatar
                                                8.5.4. Israel
                                               8.5.5. South Africa
                                                8.5.6. Nigeria
                                                8.5.7. Kenya
                                                8.5.8. Egypt
                                              8.5.9. Rest of MEA
                                              
                                 8.5.3. By Application 
8.5.4. By Type

8.5.5. Countries & Segments - Market Attractiveness Analysis

 Chapter 9. Consumer Healthcare Market– Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
 9.1 Abbott Laboratories Inc.
 9.2  American Health Corporation
9.3 BASF SE
 9.4 Bayer AG
9.5 Bionova Lifesciences
9.6 Boehringer Ingelheim GmbH
9.7 Eli Lilly and Company
9.8 Endo Pharmaceuticals PLC 
9.9 Gemini Pharmaceuticals
9.10 Geneva Biocare
 9.11 GlaxoSmithKline plc
 9.12 Glenmark Pharmaceuticals Ltd.
 9.13 Ipsen SA
 9.14 Jasco Group of Companies
 9.15 Johnson & Johnson Private Ltd
 9.16 Koninklijke DSM N.V.
 9.17 Lonza Group Ltd.
9.18 Novartis AG
9.19 Pfizer Inc.
 9.20 Piramal Enterprises Ltd.
 9.21 PureTek Corporation
9.22 Reckitt Benckiser (RB) Group PL
9.23 Reckitt Benckiser LLC.
9.24 ROHN HealthCar
9.25 Sanofi S.A.
9.26 Stanex Drugs & Chemicals Pvt. Ltd
9.27 Sterling Pharmaceutical Services LLC
9.28 Sun Pharmaceutical Industries Limited
 9.29 Takeda Pharma
9.30 Teva Pharmaceutical Industries Ltd.